1
USPSTF Guidelines - 2025/2026 Exam
Questions with 100% Correct Answers |
Latest Update
Abdominal Aortic Aneurysm: Screening - 🧠 ANSWER ✔✔The USPSTF
recommends 1-time screening for abdominal aortic aneurysm (AAA) with
ultrasonography in men aged 65 to 75 years who have ever smoked.
Anxiety in Children and Adolescents: Screening - 🧠 ANSWER ✔✔The USPSTF
recommends screening for anxiety in children and adolescents aged 8 to 18 years.
Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality:
Preventive Medication - 🧠 ANSWER ✔✔The USPSTF recommends the use of
low-dose aspirin (81 mg/day) as preventive medication after 12 weeks of gestation
in persons who are at high risk for preeclampsia.
See the Practice Considerations section for information on high risk and aspirin
dose.
1
COPYRIGHT©NINJANERD 2025/2026. YEAR PUBLISHED 2025. COMPANY REGISTRATION NUMBER: 619652435. TERMS OF USE. PRIVACY
STATEMENT. ALL RIGHTS RESERVED
, 2
Asymptomatic Bacteriuria in Adults: Screening - 🧠 ANSWER ✔✔The USPSTF
recommends screening for asymptomatic bacteriuria using urine culture in
pregnant persons.
BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic
Testing - 🧠 ANSWER ✔✔The USPSTF recommends that PCP assess women with
a personal or family history of breast, ovarian, tubal, or peritoneal cancer or who
have an ancestry associated with BRCA1/2 gene mutations with an appropriate
brief familial risk assessment tool.
Women with a positive result on the risk assessment tool should receive genetic
counseling and, if indicated after counseling, genetic testing.
Breast Cancer: Medication Use to Reduce Risk: women at increased risk for breast
cancer aged 35 years or older - 🧠 ANSWER ✔✔The USPSTF recommends that
clinicians offer to prescribe risk-reducing medications, such as tamoxifen,
raloxifene, or aromatase inhibitors, to women who are at increased risk for breast
cancer and at low risk for adverse medication effects.
2
COPYRIGHT©NINJANERD 2025/2026. YEAR PUBLISHED 2025. COMPANY REGISTRATION NUMBER: 619652435. TERMS OF USE. PRIVACY
STATEMENT. ALL RIGHTS RESERVED
USPSTF Guidelines - 2025/2026 Exam
Questions with 100% Correct Answers |
Latest Update
Abdominal Aortic Aneurysm: Screening - 🧠 ANSWER ✔✔The USPSTF
recommends 1-time screening for abdominal aortic aneurysm (AAA) with
ultrasonography in men aged 65 to 75 years who have ever smoked.
Anxiety in Children and Adolescents: Screening - 🧠 ANSWER ✔✔The USPSTF
recommends screening for anxiety in children and adolescents aged 8 to 18 years.
Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality:
Preventive Medication - 🧠 ANSWER ✔✔The USPSTF recommends the use of
low-dose aspirin (81 mg/day) as preventive medication after 12 weeks of gestation
in persons who are at high risk for preeclampsia.
See the Practice Considerations section for information on high risk and aspirin
dose.
1
COPYRIGHT©NINJANERD 2025/2026. YEAR PUBLISHED 2025. COMPANY REGISTRATION NUMBER: 619652435. TERMS OF USE. PRIVACY
STATEMENT. ALL RIGHTS RESERVED
, 2
Asymptomatic Bacteriuria in Adults: Screening - 🧠 ANSWER ✔✔The USPSTF
recommends screening for asymptomatic bacteriuria using urine culture in
pregnant persons.
BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic
Testing - 🧠 ANSWER ✔✔The USPSTF recommends that PCP assess women with
a personal or family history of breast, ovarian, tubal, or peritoneal cancer or who
have an ancestry associated with BRCA1/2 gene mutations with an appropriate
brief familial risk assessment tool.
Women with a positive result on the risk assessment tool should receive genetic
counseling and, if indicated after counseling, genetic testing.
Breast Cancer: Medication Use to Reduce Risk: women at increased risk for breast
cancer aged 35 years or older - 🧠 ANSWER ✔✔The USPSTF recommends that
clinicians offer to prescribe risk-reducing medications, such as tamoxifen,
raloxifene, or aromatase inhibitors, to women who are at increased risk for breast
cancer and at low risk for adverse medication effects.
2
COPYRIGHT©NINJANERD 2025/2026. YEAR PUBLISHED 2025. COMPANY REGISTRATION NUMBER: 619652435. TERMS OF USE. PRIVACY
STATEMENT. ALL RIGHTS RESERVED
